XD三生国股票讨论区

Sunshine Guojian Pharmaceutical (Shanghai)'s weak ROE and net income decline may negatively affect the share price due to low earnings retention or inadequate capital allocation. Despite the industry's 11% growth over a 5-year period, the company's progress lags behind. Analysts predict a slight improvement in the company's earnings growth.